On the basis of these studies, food intake impacts the pharmacokinetics of semaglutide and it is necessary to advise patients to fast before administration of the drug [28]
In April 2023, the FDA wrote to the National Association of Boards of Pharmacy, expressing its concerns with the use of salt forms in compounded products
Reich, N
Chia CW, Odetunde JO, Kim W, Carlson OD, Ferrucci L, Egan JM (2014) GIP contributes to islet trihormonal abnormalities in type 2 diabetes
Retatrutide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide1 (GLP1) receptor agonist
Longer-term safety questions including effects on the pancreas, thyroid, gallbladder, and cardiovascular system remain under investigation in ongoing Phase 3 trials